The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Gastric Cancer Surgery: Morbidity and Mortality Results From a Prospective Randomized Controlled Trial Comparing D2 and Extended Para-Aortic Lymphadenectomy—Japan Clinical Oncology Group Study 9501
Abstract
Purpose: Radical gastrectomy with regional lymphadenectomy is the only curative treatment option for gastric cancer. The extent of lymphadenectomy, however, is controversial. The two European randomized trials only reported an increase in operative morbidity and mortality, but failed to show survival benefit, in the D2 lymphadenectomy group. We conducted a randomized controlled trial to compare the Japanese standard D2 and D2 + para-aortic nodal dissection. Patients and Methods: Only experienced surgeons in both procedures from 24 Japanese institutions participated in the study. Patients with potentially curable gastric adenocarcinoma (T2-subserosa, T3, or T4) who were surgically fit were intraoperatively randomized. Postoperative morbidity and hospital mortality were recorded prospectively in a fixed format and were compared between the two groups in this study. Results: A total of 523 patients were randomized between July 1995 and April 2001. Postoperative complications were reported in 24.5% of all patients. Although the morbidity for the extended surgery group (28.1%) was slightly higher than the standard group (20.9%), there was no difference in the incidence of four major complications (anastomotic leak, pancreatic fistula, abdominal abscess, pneumonia) between the two groups. Hospital mortality was reported at 0.80%: one patient in each group died of operative complications, while one from each group died of rapid progressive cancer while inpatient. Conclusion: Specialized surgeons could safely perform gastrectomy with D2 lymphadenectomy in patients with low operative risks. Para-aortic lymphadenectomy could be added without increasing major surgical complications in this setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hospital Volume and Surgical Mortality in the United States
Birkmeyer, J. D., Siewers, A. E., Finlayson, E. V. A., Stukel, T. A., Lucas, F. L., Batista, I., Welch, H. G., & Wennberg, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa012337 · Cited by 4,999
Rising incidence of adenocarcinoma of the esophagus and gastric cardia
Blot, W. J. (1991) · JAMA · doi:10.1001/jama.265.10.1287 · Cited by 2,354
The Japanese Research Society for Gastric Cancer, & Kajitani, T. (1981) · The Japanese Journal of Surgery · doi:10.1007/bf02468883 · Cited by 1,201
Bonenkamp, J. J., Songun, I., Welvaart, K., van de Velde, C. J. H., Hermans, J., Sasako, M., Plukker, J. T. M., van Elk, P., Obertop, H., Gouma, D. J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90637-1 · Cited by 1,026
Self-citationCuschieri, A., Joypaul, V., Fayers, P. M., Cook, P., Fielding, J. W. L., Craven, J. L., & Bancewicz, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90144-0 · Cited by 1,006
Gastric cancer treatment guidelines in Japan
Nakajima, T. (2002) · Gastric Cancer · doi:10.1007/s101200200000 · Cited by 569
Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites
Powell, J., & McConkey, C. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.314 · Cited by 381
Davis, P. A., & Sano, T. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00131-1 · Cited by 108
Self-citationJapan Clinical Oncology Group (JCOG)
Shimoyama, M., Fukuda, H., Saijo, N., & Yamaguchi, N. (1998) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/28.3.158 · Cited by 42
Cited by
Van Cutsem, E., Sagaert, X., Topal, B., Haustermans, K., & Prenen, H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30354-3 · Cited by 1,793
D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer
Sasako, M., Sano, T., Yamamoto, S., Kurokawa, Y., Nashimoto, A., Kurita, A., Hiratsuka, M., Tsujinaka, T., Kinoshita, T., Arai, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707035 · Cited by 1,021
Self-citationWang, F., Shen, L., Li, J., Zhou, Z., Liang, H., Zhang, X., Tang, L., Xin, Y., Jin, J., Zhang, Y., et al. (2019) · Cancer Communications · doi:10.1186/s40880-019-0349-9 · Cited by 810
Katayama, H., Kurokawa, Y., Nakamura, K., Ito, H., Kanemitsu, Y., Masuda, N., Tsubosa, Y., Satoh, T., Yokomizo, A., Fukuda, H., et al. (2016) · Surgery Today · doi:10.1007/s00595-015-1236-x · Cited by 782
Self-citationHu, Y., Huang, C., Sun, Y., Su, X., Cao, H., Hu, J., Xue, Y., Suo, J., Tao, K., He, X., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.7215 · Cited by 686
Metadata
- Authors
- Sano, T., Sasako, M., Yamamoto, S., Nashimoto, A., Kurita, A., Hiratsuka, M., Tsujinaka, T., Kinoshita, T., Arai, K., Yamamura, Y., & Okajima, K.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-07-15
- Volume
- 22
- Issue
- 14
- Pages
- 2767-2773
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2104965946
- Cited by
- 672
- References
- 9
- FWCI
- 23.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.